Neurology malpractice risk is increasingly driven by diagnostic complexity, communication breakdowns, and supervision lapses. Claims data reveal a trend toward rising severity and massive jury awards, often rooted in flawed clinical judgment, incomplete differential diagnose...
Sex and gender have specific factors that influence the risk, presentation, progression and treatment of neurological diseases. Neurological disorders affect both men and women, with differences in hormonal milieu, immune response, vascular biology and shape outcomes. Organisation in this space is a...
An artificial intelligence-based platform helps drug developers focus on creating treatments for immunology and inflammation, as well as oncology, through the largest biotech initial public offering (IPO) to date, raising $400 million in gross proceeds for clinical trials, as well as platform and pi...
Novo Nordisk announced a collaboration with a start-up, Vivtex, which gives access to technologies that could yield new oral biologics for obesity and other medical diseases. It has partnered with Vivtex, a biotech firm co-founded by MIT professor Robert Langer, to develop oral therapies for obesity...
Praxis Precision Medicine has submitted two New Drug Applications (NDAs) to the FDA for its lead neurological candidates—ulixacaltamide for essential tremor and relutrigine for marking a major pivot toward commercialisation in 2026. The FDA has granted breakthrough therapy designation to ulix...
The government has given ₹10,000 crore to the biotechnology sector in the 2026–27 Budget.As a result, India can become a significant global hub for manufacturing medicines and biotech products. Experts said this money will help improve research, build better labs, and train students. They a...
A new Hyderabad-based company, Utopia Therapeutics, is making headlines for developing a vaccine aimed at fighting obesity. Unlike traditional treatments that require daily medication or frequent injections, this vaccine trains the body’s immune system to naturally prevent fat build-up. The m...
The National Cancer Institute is doing early laboratory research to see whether ivermectin has any effect on cancer cells. This does not mean it is a proven or approved cancer treatment. So far, it has only been tested in lab settings, not shown to work in people. Much more research would be needed ...
At BioAsia in Hyderabad, experts spoke about India’s growing role in global health and life sciences during a panel called “India’s Innovation Moment: Scaling the Next Phase of Global Impact.” Government officials, industry leaders, and technology experts discussed how India ...
American Society of Clinical Oncology (ASCO) and Conexiant have launched ASCO AI in Oncology, a new online platform focused on artificial intelligence in cancer care. This platform helps cancer doctors and healthcare professionals learn how to use AI tools safely in treating patients and provide rel...
